Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy

Thrombosis and Haemostasis

Volumn 79, Issue 6, 1998, Pages 1166-1170

  Clark, P ^a   Brennand, J ^a   Conkie, J A ^a   McCall, F ^a   Greer, I A ^a   Walker, Isobel D ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; PROTEIN C; PROTEIN S;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD CLOTTING; FEMALE; HUMAN; HUMAN EXPERIMENT; NEWBORN; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM;

EID: 0031862017     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615035     Document Type: Article

References (9)

1. Pabinger I, Kyrie PA, Heistinger M, Eichinger S, Wittmann E, Lechner K. The risk of thromboembolism in asymtomatic patients with protein C and protein S deficiency: a prospective cohort study. Thromb Haemost 1994; 71 (4): 441-5.
2. Trauscht Van Horn JJ, Capeless EL, Easterling TR, Bovill EG. Pregnancy loss and thrombosis with protein C deficiency. Am J Obstet Gynecol 1992; 167 (4 Pt 1): 968-72.
3. Dekker GA, De Vries JIP, Doelitzsch PM et al. Underlying disorders associated with severe early-onset pre-eclampsia. Am J Obstet Gynecol 1995; 173 (4): 1042-8.
4. Cadroy Y, Grandjean H, Pichon J et al. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol 1993; 100 (5): 416-20.
5. Brenner B, Lanir N, Thaler I. HELLP syndrome associated with factor V R 506Q mutation. Br J Haematol 1996; 92 (4): 999-1001.
6. Preston FE, Rosendaal FR, Walker ID et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996; 348 (9032): 913-6.
7. Rai R, Regan L, Hadley E, Dave M, Cohen H. Second-trimester pregnancy loss is associated with activated protein C resistance. Br J Haematol 1996; 92 (2): 489-90.
8. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90 (3): 1004-8.
9. Koster T, Rosendaal FR, DeRonde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein-C - Leiden Thrombophilia Study. Lancet 1993; 342 (8886-7): 1503-6.